1. Home
  2. BFAM vs ASND Comparison

BFAM vs ASND Comparison

Compare BFAM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFAM
  • ASND
  • Stock Information
  • Founded
  • BFAM 1986
  • ASND 2006
  • Country
  • BFAM United States
  • ASND Denmark
  • Employees
  • BFAM N/A
  • ASND N/A
  • Industry
  • BFAM Other Consumer Services
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFAM Consumer Discretionary
  • ASND Health Care
  • Exchange
  • BFAM Nasdaq
  • ASND Nasdaq
  • Market Cap
  • BFAM 8.2B
  • ASND 7.8B
  • IPO Year
  • BFAM 1997
  • ASND 2015
  • Fundamental
  • Price
  • BFAM $137.67
  • ASND $119.15
  • Analyst Decision
  • BFAM Buy
  • ASND Strong Buy
  • Analyst Count
  • BFAM 7
  • ASND 12
  • Target Price
  • BFAM $132.33
  • ASND $187.08
  • AVG Volume (30 Days)
  • BFAM 340.6K
  • ASND 635.0K
  • Earning Date
  • BFAM 10-30-2024
  • ASND 09-03-2024
  • Dividend Yield
  • BFAM N/A
  • ASND N/A
  • EPS Growth
  • BFAM 54.76
  • ASND N/A
  • EPS
  • BFAM 1.74
  • ASND N/A
  • Revenue
  • BFAM $2,554,203,000.00
  • ASND $340,327,869.00
  • Revenue This Year
  • BFAM $13.14
  • ASND $34.82
  • Revenue Next Year
  • BFAM $9.17
  • ASND $72.71
  • P/E Ratio
  • BFAM $79.03
  • ASND N/A
  • Revenue Growth
  • BFAM 14.72
  • ASND 166.54
  • 52 Week Low
  • BFAM $71.65
  • ASND $85.29
  • 52 Week High
  • BFAM $141.90
  • ASND $161.00
  • Technical
  • Relative Strength Index (RSI)
  • BFAM 58.46
  • ASND 27.04
  • Support Level
  • BFAM $135.00
  • ASND $114.50
  • Resistance Level
  • BFAM $141.90
  • ASND $126.95
  • Average True Range (ATR)
  • BFAM 3.06
  • ASND 4.85
  • MACD
  • BFAM -0.50
  • ASND -2.33
  • Stochastic Oscillator
  • BFAM 53.62
  • ASND 15.44

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.

About ASND Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Share on Social Networks: